(19)
(11) EP 2 672 947 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
01.12.2021 Bulletin 2021/48

(45) Mention of the grant of the patent:
04.08.2021 Bulletin 2021/31

(21) Application number: 12744839.7

(22) Date of filing: 07.02.2012
(51) International Patent Classification (IPC): 
A61J 7/04(2006.01)
A61J 1/03(2006.01)
G08B 21/02(2006.01)
G07F 11/44(2006.01)
 B65D 83/04(2006.01)
A61B 5/117(2016.01)
G07F 17/00(2006.01)
(52) Cooperative Patent Classification (CPC):
G16H 20/13; G16H 40/67; A61B 5/1172; A61J 2205/70; G07F 17/0092; A61J 2200/70; A61J 2200/30; A61J 1/03; A61J 7/0409; G07F 11/44; A61J 7/0076; G16H 10/60
(86) International application number:
PCT/US2012/024118
(87) International publication number:
WO 2012/109222 (16.08.2012 Gazette 2012/33)

(54)

DEVICES, SYSTEMS AND METHODS FOR POINT OF USE MEDICATION CONTROL

VORRICHTUNGEN, SYSTEME UND VERFAHREN ZUR STEUERUNG EINER MEDIKATION AM ANWENDUNGSORT

DISPOSITIFS, SYSTÈMES ET PROCÉDÉS POUR CONTRÔLER LA MÉDICATION DANS UN POINT D'UTILISATION

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 07.02.2011 US 201113022354

(43) Date of publication of application:
18.12.2013 Bulletin 2013/51

(60) Divisional application:
21189458.9

(73) Proprietor: Dunn, Lawrence A.
Durham, NC 27705 (US)

(72) Inventor:
  • Dunn, Lawrence A.
    Durham, NC 27705 (US)

(74) Representative: Isarpatent 
Patent- und Rechtsanwälte Barth Charles Hassa Peckmann & Partner mbB Friedrichstrasse 31
80801 München
80801 München (DE)


(56) References cited: : 
WO-A2-2004/015640
US-A- 4 744 492
US-A1- 2007 156 282
US-A1- 2009 308 884
 WO-A2-2009/080309
US-A1- 2005 269 348
US-A1- 2009 308 884
US-B1- 6 962 274
   
  • None
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).